the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Broker loses RM1.45 million to bogus foreign investment scheme

JOHOR BAHRU: A female broker reported a loss of RM1.45 million, after falling victim to a fraudulent overseas stock investment scheme, in May.

Johor police chief CP M Kumar revealed that the 44-year-old woman discovered an advertisement on Facebook for a stock market investment in Hong Kong, under the name ‘Pantheon Ventures’, which offered 100 per cent profit, 25 per cent for agents and 75 per cent for investors.

He said that the victim was added to a WhatsApp group called ‘V-27 Pantheon Market Insight Academy,‘ where she received investment information, and was offered a free trip to Hong Kong to meet investors.

“Attracted by the promised returns, the victim made payments to several local bank accounts, from June to this month, totalling RM1.5 million. She also downloaded the Apex application to track her investment.

“Initially, the victim observed profits on the application and was able to withdraw some earnings, leaving a balance of RM1.45 million for continued investment,” he said in a statement today.

However, the victim was unable to withdraw her profit due to several issues, including investment arrears and non-compliance with the set rules, before being blocked from the WhatsApp group.

“The victim realised she had been scammed, and filed a police report in Muar, yesterday. The case is being investigated under Section 420 of the Penal Code,” he said.

According to Kumar, from January to yesterday (Aug 20), a total of 399 investment fraud cases were recorded, with losses totalling RM32.9 million, compared with 327 cases and RM26 million in losses reported for the same period last year.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings